Avanteca Partners
Basel, Basel-Stadtavanteca.com
Overview
A privately held asset management company based in Basel, Switzerland, that invests in early-stage life science companies. The firm focuses on innovations in new chemical or biological entities (NCEs or NBEs), vaccines, and digital health applications with a direct impact on disease. It acts as both a financial provider and a strategic partner, offering operational experience to its portfolio companies.
Portfolio Companies
4
Website
avanteca.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nanoligent | Oct 2025 | Series A | Co-investor |
| Onena Medicines | Oct 2023 | Series A | Lead |
| Bearmind | Jul 2023 | Seed | Co-investor |
| Bearmind | Mar 2023 | Seed | Co-investor |
| Nanoligent | Sep 2022 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
